Barclays PLC
- SEC CIK
- 0000312069
- Latest filing
- Aug 14, 2026
THRX holding history
Theseus Pharmaceuticals, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
THRX overviewAll 13F holders of THRXFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −32,097−100.0% | Sold out | Holders |
| Q4 2023 | 32,097 | $130.0K | <0.1% | +24,265+309.8% | Added | Holders |
| Q3 2023 | 7,832 | $21.1K | <0.1% | −533−6.4% | Reduced | Holders |
| Q2 2023 | 8,365 | $78.0K | <0.1% | −4,628−35.6% | Reduced | Holders |
| Q1 2023 | 12,993 | $115.4K | <0.1% | +4,089+45.9% | Added | Holders |
| Q4 2022 | 8,904 | $44.3K | <0.1% | +3,844+76.0% | Added | Holders |
| Q3 2022 | 5,060 | $29.0K | <0.1% | −132−2.5% | Reduced | Holders |
| Q2 2022 | 5,192 | $29.0K | <0.1% | −1,018−16.4% | Reduced | Holders |
| Q1 2022 | 6,210 | $72.0K | <0.1% | +6,210 | New | Holders |